Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut microbiome diversity and function refers to the collective variety (number and type) of microbial species present in the gastrointestinal tract and the sum of their metabolic and biological activities. Higher diversity is generally associated with ecosystem stability, resilience against pathogens, and beneficial regulatory effects on host metabolism, immune response, barrier integrity, and even mental health. Functional diversity ensures key processes—such as fermentation, vitamin synthesis, and immune modulation—occur even with different taxonomic compositions. Disruptions in diversity or in core functions can contribute to a wide spectrum of health disorders, making the gut microbiome a major research focus for understanding disease mechanisms and therapeutic strategies. However, it is not a singular druggable target but a complex, multi-species system.
Modulation of species composition and metabolic output Restoration of microbial diversity Enhancement or suppression of microbial functions (fermentation, SCFA production, immuomodulation) Inhibition of pathogenic species Suppression of inflammatory responses
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiome diversity and function (None).